FRISQ board has decided to enter into a formal exclusive process with the objective to divest its operative business to
The proposal is to enter into an exclusive process to finalize the necessary due diligence required by Cambio, with the objective to reach a final and binding offer to acquire the operative business of FRISQ by the beginning of September. FRISQ will then call an EGM to secure the required shareholders vote to finalize a potential transaction. The target is to achieve closing of the deal no later than the end of September.
During the exclusivity period Cambio will extend a loan of maximum
FRISQ will during this time of exclusivity discontinue discussions with other potential acquirers.
"We are very excited about becoming a part of the Cambio family as it will allow FRISQ to scale more rapidly as part of one of the largest EMR systems in the Nordics. We also see that this development will allow FRISQ to more resourcefully meet our customers' needs both in the short and long term" says
"We are truly excited about the possibilities of being able to welcome FRISQ, its employees, partners and customers to Cambio. The portfolio of FRISQ will fill a very important part of our offering going forward but more importantly we will add lots of new, fantastic talent across the board of our business. Now our focus will be on completing the Due Diligence and conclude the transaction during Q3" says
More information will be published when it is available.
About FRISQ
FRISQ is a healthtech company built on the conviction that the quality of the care you get should not be dependent on your ability to navigate a complex system and constantly evolving treatments. The software solution FRISQ Care enables the creation of personalized, digital care plans that facilitate collaboration and secure information sharing between care teams, doctors and patients through the same platform.
About Cambio
This disclosure contains information that Sanolium is obliged to make public pursuant to the
For further information, please contact:
CEO
rami.avidan@cambio.se
Chief Marketing & Communication Officer
+46 7 0 79 34 83
jenny.styren@cambio.se
https://news.cision.com/sanolium/r/cambio-and-frisq-enters-into-a-formal-exclusive-process-to-divest-frisq-to-cambio-with-a-target-tran,c3603834
https://mb.cision.com/Main/19708/3603834/1606468.pdf
(c) 2022 Cision. All rights reserved., source